Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Mammary Gland Biology and Neoplasia
Metadata
Title
Integrins in Mammary Gland Development and Differentiation of Mammary Epithelium
Authors
Ilaria Taddei
Marisa M. Faraldo
Jérôme Teulière
Marie-Ange Deugnier
Jean Paul Thiery
Marina A. Glukhova
Publication date
01-10-2003
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 4/2003
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1023/B:JOMG.0000017426.74915.b9

Other articles of this Issue 4/2003

Journal of Mammary Gland Biology and Neoplasia 4/2003 Go to the issue

OriginalPaper

Cell Surface β1,4-Galactosyltransferase Function in Mammary Gland Morphogenesis: Insights from Transgenic and Knockout Mouse Models

OriginalPaper

The Organization of Tight Junctions in Epithelia: Implications for Mammary Gland Biology and Breast Tumorigenesis

Preface

Preface: Cell Adhesion in Mammary Gland Biology and Neoplasia

OriginalPaper

Wnt-Cadherin Connections in Normal and Neoplastic Mammary Epithelium

OriginalPaper

Dystroglycan: Emerging Roles in Mammary Gland Function

OriginalPaper

Developmental Regulation of Gap Junctions and Their Role in Mammary Epithelial Cell Differentiation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits